Avenue Therapeutics (ATXI) Q3 2024 Earnings

Aug 9Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-15.4
-10.08
-4.76
0.56

Details

Expected EPS
-1.05
Actual EPS
-6.43
Surprise EPS
-5.38
Surprise Percent
-512.38%

Description

⁨Avenue Therapeutics⁩ (⁦ATXI⁩) has reported earnings of ⁦-6.43⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts